These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37882497)

  • 1. High sensitivity troponin I as a biomarker for cardiac allograft vasculopathy: Evaluation of diagnostic potential and clinical utility.
    Patel K; Yadalam A; DeStefano R; Desai S; Almuwaqqat Z; Ko YA; Alras Z; Martini MA; Ejaz K; Alvi Z; Varounis C; Murtagh G; Gupta D; Book W; Quyyumi AA
    Clin Transplant; 2024 Jan; 38(1):e15168. PubMed ID: 37882497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
    Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
    J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
    J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in Heart Transplant Patients According to the Grading Scheme Developed by the International Society for Heart and Lung Transplantation (ISHLT).
    Zielińska K; Kukulski L; Wróbel M; Przybyłowski P; Rokicka D; Strojek K
    Ann Transplant; 2022 Feb; 27():e933420. PubMed ID: 35165250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cardiac allograft vasculopathy on dual source computed tomography in heart transplant recipients: comparison with invasive coronary angiography.
    Ojha V; Ganga KP; Mani A; Jagia P; Gulati G; Seth S; Nakra T; Arava S; Kumar S; Ray R; Sharma S
    Br J Radiol; 2022 Jun; 95(1134):20211237. PubMed ID: 35230144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients: A pediatric heart transplant society analysis.
    D'Addese L; Cantor RS; Koehl D; Reardon L; Ameduri R; Bock M; Morrison A; White S; Wisotzkey B; Kirklin JK; Godown J
    J Heart Lung Transplant; 2023 Jan; 42(1):115-123. PubMed ID: 36328858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients.
    Nagumo S; Gallinoro E; Candreva A; Mizukami T; Monizzi G; Kodeboina M; Verstreken S; Dierckx R; Heggermont W; Bartunek J; Goethals M; Buytaert D; De Bruyne B; Sonck J; Collet C; Vanderheyden M
    J Interv Cardiol; 2020; 2020():9835151. PubMed ID: 32733172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Sensitivity Troponin T and Soluble Form of AXL as Long-Term Prognostic Biomarkers after Heart Transplantation.
    Mirabet S; García-Osuna A; Garcia de Frutos P; Ferrero-Gregori A; Brossa V; Lopez L; Leta R; Garcia-Picart J; Padro JM; Sánchez-Quesada JL; Cinca J; Ordonez-Llanos J; Roig E
    Dis Markers; 2018; 2018():6243529. PubMed ID: 30245754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between High Sensitivity Troponin I and NTproBNP With Rejection and Graft Loss in Pediatric Heart Transplant Recipients.
    Magnetta DA; Jackson L; Zeevi A; Turnquist HR; Miller SA; West SC; Murtagh G; Feingold B
    Pediatr Transplant; 2024 Nov; 28(7):e14858. PubMed ID: 39320013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients.
    Clemmensen TS; Eiskjær H; Løgstrup BB; Ilkjær LB; Poulsen SH
    J Heart Lung Transplant; 2017 May; 36(5):567-576. PubMed ID: 28089194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative flow ratio computed from invasive coronary angiography as a predictor for cardiac allograft vasculopathy after cardiac transplant.
    Shah H; Lee I; Rao S; Suddath W; Rodrigo M; Mohammed S; Molina E; García-Garcia HM; Kenigsberg BB
    Int J Cardiovasc Imaging; 2024 Feb; 40(2):451-458. PubMed ID: 38117378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients.
    Nelson LM; Rossing K; Ihlemann N; Boesgaard S; Engstrøm T; Gustafsson F
    Clin Transplant; 2020 Dec; 34(12):e14124. PubMed ID: 33068292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal mitochondrial function and morphology in heart transplanted patients with cardiac allograft vasculopathy.
    Lichscheidt ED; Jespersen NR; Nielsen BRR; Berg K; Seefeldt J; Nyengaard JR; Bøtker HE; Eiskjær H
    J Heart Lung Transplant; 2022 Jun; 41(6):732-741. PubMed ID: 35249802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.
    Tremblay-Gravel M; Racine N; de Denus S; Ducharme A; Pelletier GB; Giraldeau G; Liszkowski M; Parent MC; Carrier M; Fortier A; White M
    JACC Heart Fail; 2017 Dec; 5(12):891-901. PubMed ID: 29191295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro- and macrovascular cardiac allograft vasculopathy in relation to 91 cardiovascular biomarkers in heart transplant recipients-An exploratory study.
    Bjerre KP; Clemmensen TS; Poulsen SH; Hvas AM; Holm NR; Grove EL; Bouchelouche K; Kristensen SD; Eiskjaer H
    Clin Transplant; 2021 Jan; 35(1):e14133. PubMed ID: 33128247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Flow Velocity Reserve and Myocardial Deformation Predict Long-Term Outcomes in Heart Transplant Recipients.
    Bjerre KP; Clemmensen TS; Poulsen SH; Hvas AM; Løgstrup BB; Grove EL; Flyvholm F; Kristensen SD; Eiskjær H
    J Am Soc Echocardiogr; 2021 Dec; 34(12):1294-1302. PubMed ID: 34325007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac allograft vasculopathy and survival in pediatric heart transplant recipients transitioned to adult care.
    Rodenas-Alesina E; Aleksova N; Stubbs M; Foroutan F; Kozuszko S; Posada JD; McDonald M; Moayedi Y; Ross H; Dipchand A
    J Heart Lung Transplant; 2024 Feb; 43(2):229-237. PubMed ID: 37704160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudy.
    Nelson LM; Andreassen AK; Arora S; Andersson B; Gude E; Eiskjaer H; Rådegran G; Dellgren G; Gullestad L; Gustafsson F
    Transpl Int; 2020 May; 33(5):517-528. PubMed ID: 31958178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive aortic pulse pressure is linked to cardiac allograft vasculopathy after heart transplantation.
    Park HW; Ozcan I; Toya T; Ahmad A; Kanaji Y; Kushwaha SS; Lerman LO; Lerman A
    Int J Cardiol; 2023 Jan; 370():167-174. PubMed ID: 36346255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.